Fore Capital’s Precigen PGEN Stock Holding History

Fore Capital’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-68,500	Closed	-$472K	–	72
2021 Q1	$472K	Buy	+68,500	New	+$579K	0.09%	54
2019 Q2	–	Sell	-20,000	Closed	-$105K	–	87
2019 Q1	$105K	Sell	20,000 -30,000	-60%	-$208K	0.02%	59
2018 Q4	$327K	Buy	50,000 +35,000	+233%	+$392K	0.16%	46
2018 Q3	$258K	Sell	15,000 -5,000	-25%	-$74.4K	0.08%	48
2018 Q2	$279K	Hold	20,000	–	–	0.1%	33
2018 Q1	$307K	Sell	20,000 -47,000	-70%	-$672K	0.09%	53
2017 Q4	$772K	Buy	+67,000	New	+$998K	0.3%	44

Other funds holding PGEN

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Occam Crest Management Darien, Connecticut $165M AUM

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return